Φορτώνει......
Exosome therapeutics for COVID‐19 and respiratory viruses
Respiratory viral diseases are a leading cause of mortality in humans. They have proven to drive pandemic risk due to their complex transmission factors and viral evolution. However, the slow production of effective antiviral drugs and vaccines allows for outbreaks of these diseases, emphasizing a c...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | View (Beijing) |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7995024/ https://ncbi.nlm.nih.gov/pubmed/34766162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/VIW.20200186 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|